|
|
Huang-Ge Zhang, Martin Fleck, Earl R. Kern, Di Liu, Yongming Wang, Hui-Chen Hsu, Pingar Yang, Zheng Wang, David T. Curiel, Tong Zhou, John D. Mountz
J Clin Invest. 2000;
105(6):813
doi:10.1172/JCI8236
Abstract |
Full text
| PDF

W
e assessed the effect of modified antigen presenting cells (APCs) expressing high levels of Fas ligand (APC-FasL) on post-viral chronic inflammatory disease. FasL-deficient B6-gld/gld mice infected with murine cytomegalovirus (MCMV) cleared the virus from their lungs, kidneys, and livers within 2 weeks of infection. However, inflammation persisted in these organs for more than 8 weeks, with a chronically increased T-cell response to MCMV-infected APCs and production of autoantibodies. Administration of APC-AdFasL at 4 weeks suppressed this inflammation and diminished the T-cell response and autoantibody production. APC-AdFasL that had been transfected with ultraviolet-irradiated MCMV were more effective than uninfected APC-AdFasL in ameliorating the chronic inflammation. APC-AdFasL migrated preferentially to the spleen, where they triggered apoptosis of lymphocytes in the marginal zone of the spleen. These results confirm that Fas-mediated apoptosis is not required for clearance of virus, but is required for down-modulation of the virally induced chronic inflammatory response. This organwide effect of APC-AdFasL appears to be mediated by elimination of activated T lymphocytes in the spleen before their emigration to the target organs.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies
Karine Crozat, Eric Vivier, Marc Dalod |
Immunol Rev |
2009 |
.
|
Angiogenesis in eye disease: immunity gained or immunity lost?
Thomas A. Ferguson, Rajendra S. Apte |
Semin Immunopathol |
2008 |
.
|
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells
C. Schutz, M. Fleck, A. Mackensen, A. Zoso, D. Halbritter, J. P. Schneck, M. Oelke |
Blood |
2008 |
.
|
Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma
Ya-Hui Chuang, Jau-Ling Suen, Bor-Luen Chiang |
J Mol Med-JMM |
2006 |
.
|
Tumor counterattack: fact or fiction?
Frederik H. Igney, Peter H. Krammer |
Cancer Immunol Immunother |
2005 |
.
|
Renal cell–expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis
Volker Vielhauer, George Stavrakis, Tanya N. Mayadas |
Journal Clinical Investigation |
2005 |
.
|
Fas/FasL interaction: A novel immune therapy approach with immobilized biologicals
Martin Scholz, Jindrich Cinatl |
Res Rev |
2005 |
.
|
Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections
Masahiro Kusuhara, Hiroyuki Matsue |
Exp Dermatol |
2005 |
.
|
The multiple roles of Fas ligand in the pathogenesis of infectious diseases
D. H. Dockrell |
Clin Microbiol Infect |
2003 |
.
|
Activation-induced cell death in T cells
Douglas R. Green, Nathalie Droin, Michael Pinkoski |
Immunol Rev |
2003 |
.
|
Killing of naive T cells by CD95L-transfected dendritic cells (DC):in vivo study using killer DC-DC hybrids and CD4+ T cells from DO11.10 mice
Masahiro Kusuhara, Keiko Matsue, Dale Edelbaum, Julie Loftus, Akira Takashima, Hiroyuki Matsue |
Eur J Immuno |
2002 |
.
|
Biology and significance of T-cell apoptosis in the liver
Sun Park, Debbie Murray, Beena John, I Nicholas Crispe |
Immunol Cell Biol |
2002 |
.
|
BXD recombinant inbred mice represent a novel T cell-mediated immune response tumor model
William E. Grizzle, John D. Mountz, Ping-Ar Yang, Xin Xu, Sheher Sun, Gary E. Van Zant, Robert W. Williams, Hui-Chen Hsu, Huang-Ge Zhang |
Int J Cancer |
2002 |
.
|
Regulation of tumor necrosis factor ?-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt
Huang-Ge Zhang, Yongming Wang, Jin Fu Xie, Xiu Liang, Di Liu, Pingar Yang, Hui-Chen Hsu, R. B. Ray, John D. Mountz |
Arth Rheumat |
2001 |
.
|
Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent toMycoplasma pulmonis infection
Hui-Chen Hsu, Huang-Ge Zhang, Gwan Gyu Song, Jingping Xie, Di Liu, Pingar Yang, Martin Fleck, Winfried Wintersberger, Tong Zhou, Carl K. Edwards, John D. Mountz |
Arth Rheumat |
2001 |
.
|
Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes
William J. Murphy |
Journal Clinical Investigation |
2000 |
.
|
|
|
|